Search results
Results from the WOW.Com Content Network
Injection of hCG as a trigger for ovulation confers a risk of ovarian hyperstimulation syndrome, especially in patients with polycystic ovary syndrome who have been hyperstimulated during previous assisted reproduction cycles. [12] Complications of TVOR include injury to pelvic organs, hemorrhage, and infection.
Medroxyprogesterone acetate; Clinical data; Pronunciation / m ɛ ˌ d r ɒ k s i p r oʊ ˈ dʒ ɛ s t ər oʊ n ˈ æ s ɪ t eɪ t / me-DROKS-ee-proh-JES-tər-ohn ASS-i-tayt [1] Trade names: Depo-Provera, others
Response predictors determine the protocol for ovulation suppression as well as dosage of medication used for hyperstimulation. Response prediction based on ovarian reserve confers substantially higher live birth rates, lower total costs and more safety.
The best way to evaluate for an ovarian cyst is usually an ultrasound of the pelvis." Dr. Staci Tanouye , a board-certified ob-gyn, agrees, saying that most ovarian cysts don't cause symptoms.
Ovarian hyperstimulation syndrome is particularly associated with injection of a hormone called human chorionic gonadotropin (hCG) which is used for inducing final oocyte maturation and/or triggering oocyte release. The risk is further increased by multiple doses of hCG after ovulation and if the procedure results in pregnancy. [2]
On the mend! Chrishell Stause is feeling better after undergoing a medical procedure to remove an ovarian cyst. Celebrity Health Scares Through the Years Read article “[I] had a minor surgery ...
An ovarian cyst is a fluid-filled sac within the ovary. [1] They usually cause no symptoms, [1] but occasionally they may produce bloating, lower abdominal pain, or lower back pain. [1] The majority of cysts are harmless. [1] [2] If the cyst either breaks open or causes twisting of the ovary, it may cause severe pain. [1]
[citation needed] It is administered as either multiple 0.25 mg daily subcutaneous injections or as a single-dose 3 mg subcutaneous injection. The duration of the 3 mg single dose is four days; if human chorionic gonadotropin (hCG) is not administered within four days, a daily 0.25 mg dose is started and continued until hCG is administered.